- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07946744
Physical Frailty Intervention for Older Adults With Hypertension and Physical Frailty (PFIM)
Development and Evaluation of Physical Frailty Intervention Module for Older Adults With Hypertension in Shandong Province, China
Physical frailty is a common health concern among older adults with hypertension and may contribute to reduced physical function, loss of independence, and poorer quality of life. This study aims to evaluate the effectiveness of a 12-week nurse-led Physical Frailty Intervention Module (PFIM) among community-dwelling older adults with hypertension and physical frailty in Shandong Province, China.
This nonrandomized controlled study will recruit 124 participants aged 60 years or older from three primary healthcare institutions. Two institutions will be assigned to the intervention group, which will receive the PFIM in addition to usual care, while one institution will serve as the control group and provide usual care only.
The PFIM is based on the Health Action Process Approach (HAPA) and combines simplified Baduanjin exercise, basic nutrition guidance, hypertension self-management education, and behavioral support. The intervention includes nurse-led group sessions, individualized home-based exercise, and follow-up support over 12 weeks.
Physical frailty will be the primary outcome. Physical performance, nutritional status, health literacy, perceived social support, depressive symptoms, and quality of life will be assessed as secondary outcomes at baseline and after 12 weeks.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This study is the third phase of a multiphase research project involving the development, validation, and evaluation of a Physical Frailty Intervention Module (PFIM) for older adults with hypertension and physical frailty.
A pragmatic, two-arm, nonrandomized controlled quasi-experimental design will be used. The study will be conducted at three primary healthcare institutions in Yanzhou District, Jining, Shandong Province, China. Two institutions will be allocated to the intervention group and one to the control group to minimize contamination. The planned sample size is 124 participants, with 62 participants per group.
The 12-week PFIM is informed by the Health Action Process Approach (HAPA) and delivered by trained nurses. It comprises three stages:
Weeks 1-4 focus on motivation and participation preparation through weekly face-to-face group education sessions addressing physical frailty, hypertension, nutrition, exercise safety, and behavioral change.
Weeks 5-8 emphasize action planning and behavior initiation through weekly group sessions and home-based simplified Baduanjin practice two to three times weekly for 15-20 minutes per session.
Weeks 9-12 focus on behavior maintenance through continued home practice, progressing toward 20-30 minutes per session when appropriate, with group sessions in Weeks 9 and 12 and telephone or WeChat follow-up in Weeks 10 and 11.
Standing or seated simplified Baduanjin exercises will be assigned according to participants' physical performance and clinical safety assessments. The control group will receive usual hypertension care without the structured PFIM.
The primary outcome is physical frailty severity, measured using the FRAIL Scale. Secondary outcomes include physical performance (SPPB), nutritional status (MNA-SF), health literacy (HLS-SF12), perceived social support (PSSS), depressive symptoms (GDS-15), and quality of life (OPQOL-brief). Outcomes will be assessed at baseline and immediately after the 12-week intervention.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Shandong
-
Jining, Shandong, Chine, 272100
- Caohe Town Health Center
-
Contact:
- YUAN DONG
- Numéro de téléphone: 60 1123736187
- E-mail: dongyuan0407@163.com
-
Jining, Shandong, Chine, 272100
- Jiuxianqiao Subdistrict Community Health Service Center
-
Contact:
- YUAN DONG
- Numéro de téléphone: 601123736187
- E-mail: dongyuan0407@163.com
-
Jining, Shandong, Chine, 272100
- Yandian Central Health Center
-
Contact:
- YUAN DONG
- Numéro de téléphone: 60 1123736187
- E-mail: dongyuan0407@163.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Aged 60 years or older.
- Physician-diagnosed hypertension or current use of physician-prescribed antihypertensive medication.
- Physical frailty, defined as a FRAIL Scale score of 3 or higher.
- Community-dwelling and residing within the catchment area of one of the participating primary healthcare institutions.
- Adequate cognitive and communication abilities to understand study procedures, communicate in Mandarin or the local dialect, complete questionnaires with or without assistance, and provide written informed consent.
- Medically stable and considered fit for light-to-moderate physical activity by the treating physician.
Exclusion Criteria:
- Major acute illness requiring hospitalization within the preceding three months, such as acute myocardial infarction, acute stroke, or acute decompensated heart failure.
- Current participation in another structured health promotion, rehabilitation, or exercise program.
- Disabling stroke, active or advanced cancer, advanced heart failure, severe chronic obstructive pulmonary disease, or another serious medical condition that makes participation unsafe or substantially limits life expectancy.
- Adjusted Montreal Cognitive Assessment (MoCA) score below the prespecified education-specific thresholds: <14 for illiterate participants, <15 for those with primary-school education, or <21 for those with junior-secondary education or above. One additional point is applied for fewer than 12 years of education, up to a maximum score of 30.
- Major visual, hearing, speech, or other communication impairment that prevents meaningful participation.
- Severe uncontrolled psychiatric disorder, major neurocognitive disorder, or end-stage disease that prevents comprehension, cooperation, or safe participation.
- Any other condition considered medically unsuitable for participation by the treating physician.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: PFIM Intervention Group
Participants in this group will receive the 12-week nurse-led Physical Frailty Intervention Module (PFIM) in addition to usual primary healthcare for hypertension. The intervention includes simplified Baduanjin exercise, nutrition guidance, hypertension self-management education, individualized action planning, self-monitoring, and follow-up support. |
The Physical Frailty Intervention Module (PFIM) is a 12-week nurse-led behavioral intervention based on the Health Action Process Approach (HAPA). During Weeks 1-4, participants attend weekly group education sessions on physical frailty, hypertension, nutrition, and exercise safety. During Weeks 5-8, participants attend weekly group sessions and begin home-based simplified Baduanjin practice 2-3 times per week for 15-20 minutes per session. During Weeks 9-12, home practice continues, progressing toward 20-30 minutes per session as tolerated, with group sessions in Weeks 9 and 12 and telephone or WeChat follow-up in Weeks 10 and 11. Standing or seated exercises are assigned according to physical performance and safety assessments. The intervention is provided in addition to usual hypertension care. |
|
Aucune intervention: Usual Care Control Group
Participants in the control group will receive usual primary healthcare for hypertension, including routine blood pressure monitoring, medication management, general lifestyle advice, and regular follow-up. No structured Physical Frailty Intervention Module (PFIM) will be provided during the 12-week study period. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Physical Frailty Severity Measured by the FRAIL Scale
Délai: Baseline (Week 0) and Week 12
|
Physical frailty will be assessed using the five-item FRAIL Scale, covering fatigue, resistance, ambulation, illnesses, and weight loss. Each item is scored 0 or 1, yielding a total score from 0 to 5. Higher scores indicate greater frailty severity. Change will be calculated as the Week 12 score minus the baseline score. |
Baseline (Week 0) and Week 12
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Physical Performance Measured by the Short Physical Performance Battery (SPPB)
Délai: Baseline (Week 0) and Week 12
|
Physical performance will be assessed using the Short Physical Performance Battery (SPPB), comprising balance, 4-meter gait speed, and repeated chair stands. Each component is scored from 0 to 4, yielding a total score from 0 to 12. Higher scores indicate better physical performance. Change is the Week 12 score minus the baseline score. |
Baseline (Week 0) and Week 12
|
|
Change in Nutritional Status Measured by the Mini Nutritional Assessment-Short Form (MNA-SF)
Délai: Baseline (Week 0) and Week 12
|
Nutritional status will be assessed using the six-item Mini Nutritional Assessment-Short Form (MNA-SF). Total scores range from 0 to 14, with higher scores indicating better nutritional status. Change is the Week 12 score minus the baseline score. |
Baseline (Week 0) and Week 12
|
|
Change in Health Literacy Measured by the Health Literacy Survey-Short Form 12 (HLS-SF12)
Délai: Baseline (Week 0) and Week 12
|
Health literacy will be measured using the 12-item Health Literacy Survey-Short Form (HLS-SF12), covering healthcare, disease prevention, and health promotion. Responses are converted to a standardized index ranging from 0 to 50. Higher scores indicate better health literacy. Change is the Week 12 index minus the baseline index. |
Baseline (Week 0) and Week 12
|
|
Change in Perceived Social Support Measured by the Perceived Social Support Scale (PSSS)
Délai: Baseline (Week 0) and Week 12
|
Perceived social support will be assessed using the 12-item Perceived Social Support Scale (PSSS), covering support from family, friends, and significant others. Each item is rated from 1 to 7, giving a total score from 12 to 84. Higher scores indicate greater perceived social support. Change is the Week 12 score minus the baseline score. |
Baseline (Week 0) and Week 12
|
|
Change in Depressive Symptoms Measured by the 15-Item Geriatric Depression Scale (GDS-15)
Délai: Baseline (Week 0) and Week 12
|
Depressive symptoms will be assessed using the 15-item Geriatric Depression Scale (GDS-15). Each item is scored 0 or 1, giving a total score from 0 to 15. Higher scores indicate more severe depressive symptoms. Change is the Week 12 score minus the baseline score. |
Baseline (Week 0) and Week 12
|
|
Change in Quality of Life Measured by the Brief Older People's Quality of Life Questionnaire (OPQOL-brief)
Délai: Baseline (Week 0) and Week 12
|
Quality of life will be assessed using the 13-item Brief Older People's Quality of Life Questionnaire (OPQOL-brief). Items are scored on a five-point scale and coded so that higher scores indicate better quality of life. Total scores range from 13 to 65. Change is the Week 12 score minus the baseline score. |
Baseline (Week 0) and Week 12
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- USM/JEPeM/KK/26040291
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Individual participant-level data will not be shared outside the study team due to participant privacy and confidentiality considerations.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .